MAIA Biotechnology: Invitation to The ThinkEquity Conference – Shoreline Beacon

Breadcrumb Trail Links

Chicago, Illinois(Newsfile Corp. October 12, 2022) MAIA Biotechnology (NYSE: MAIA), a targeted therapy, immuno-oncology company focused on developing potential first-in-class oncology drugs, will be participating in The ThinkEquity Conference, which will take place on October 26, 2022 at The Mandarin Oriental Hotel in New York.

This advertisement has not loaded yet, but your article continues below.

Vlad Vitoc will be presenting at 3:00 PM ET on October 26th. Interested parties can register to attend here. Members of the MAIA Biotechnology management will also be holding one-on-one investor meetings throughout the day.

The presentation will also be live-streamed at the following link.

About MAIA Biotechnology

MAIA is a targeted therapy, immuno-oncology company focused on the development and commercialization of potential first-in-class drugs with novel mechanisms of action that are intended to meaningfully improve and extend the lives of people with cancer. Our lead program is THIO, a potential first-in-class cancer telomere targeting agent in clinical development for the treatment of NSCLC patients with telomerase-positive cancer cells. For more information, please visit http://www.maiabiotech.com.

This advertisement has not loaded yet, but your article continues below.

About The ThinkEquity Conference

The ThinkEquity Conference will gather industry insiders, investors and leading executives from around the world on October 26th in New York. Attendees can expect a full day of company presentations, panel discussions, one-on-one investor meetings and more.

Featured sectors include AI/Big data technology, Biotechnology, EV/EV Infrastructure, Metals & Mining and Oil & Gas.

To register to attend The ThinkEquity Conference, please follow this link.

For further information:Joseph McGuireChief Financial Officer904-228-2603jmcguire@maiabiotech.com

Source: MAIA Biotechnology

#distro

This advertisement has not loaded yet, but your article continues below.

Postmedia is committed to maintaining a lively but civil forum for discussion and encourage all readers to share their views on our articles. Comments may take up to an hour for moderation before appearing on the site. We ask you to keep your comments relevant and respectful. We have enabled email notificationsyou will now receive an email if you receive a reply to your comment, there is an update to a comment thread you follow or if a user you follow comments. Visit our Community Guidelines for more information and details on how to adjust your email settings.

The rest is here:
MAIA Biotechnology: Invitation to The ThinkEquity Conference - Shoreline Beacon